Dr. Corey Cutler, MD, MPH
Claim this profileDana-Farber Cancer Institute
Studies Bronchiolitis Obliterans Syndrome
Studies GVHD
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Corey Cutler, MD, MPH is currently running
Belumosudil
for Bronchiolitis Obliterans Syndrome
The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who have been newly diagnosed or have developing (early stage) bronchiolitis obliterans syndrome (BOS). The name of the study drugs involved in this study are: * Belumosudil (an immunotherapy) * Fluticasone (an intranasal corticosteroid) * Azithromycin (an antibiotic) * Montelukast (a leukotriene receptor antagonist) * Prednisone (a corticosteroid)
Recruiting1 award Phase 217 criteria
Belumosudil
for Graft-versus-Host Disease
This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host disease remains a major complication of stem cell transplantation and can involve multiple organ systems. Belumosudil is a ROCK2 selective inhibitor that works to reduce the immune system response causing the chronic graft versus host disease. Giving belumosudil may better treat patients with chronic graft versus host disease and prevent the need for starting additional immune suppressive medications.
Recruiting0 awards Phase 214 criteria
More about Corey Cutler, MD, MPH
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Corey Cutler, MD, MPH has experience with
- Belumosudil
- Azithromycin
- Fluticasone
- Montelukast
- Prednisone
- Unlicensed CBU
Breakdown of trials Corey Cutler, MD, MPH has run
Bronchiolitis Obliterans Syndrome
Bronchiolitis Obliterans
Pulmonary Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Corey Cutler, MD, MPH specialize in?
Corey Cutler, MD, MPH focuses on Bronchiolitis Obliterans Syndrome and GVHD. In particular, much of their work with Bronchiolitis Obliterans Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Corey Cutler, MD, MPH currently recruiting for clinical trials?
Yes, Corey Cutler, MD, MPH is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Corey Cutler, MD, MPH has studied deeply?
Yes, Corey Cutler, MD, MPH has studied treatments such as Belumosudil, Azithromycin, Fluticasone.
What is the best way to schedule an appointment with Corey Cutler, MD, MPH?
Apply for one of the trials that Corey Cutler, MD, MPH is conducting.
What is the office address of Corey Cutler, MD, MPH?
The office of Corey Cutler, MD, MPH is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02115 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.